Skip to main content
Fig. 1 | Journal of Pharmaceutical Policy and Practice

Fig. 1

From: Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations

Fig. 1

Methods summary. HTA Health Technology Assessment. *HTA agencies and Universities from select countries: Singapore: Agency for Care Effectiveness (ACE); Canada: Drug and Health Technology Agency (CADTH); England: National Institute for Health and Care Excellence (NICE) and University of York; Malaysia: Malaysian Health and Technology Assessment (MaHTAS); Republic of Korea: National Evidence-based Healthcare Collaborating Agency (NECA); Australia: Royal Adelaide Hospital **Australia, Republic of Korea, and England

Back to article page